The Medline beds FDA warning issued on October 29, 2026, is one of the broadest medical-device safety actions of the year: it covers every Medline-brand bed and its accessories, after the company reported two deaths and 16 serious injuries linked to fire, entrapment and asphyxiation hazards. Medline is discontinuing all of its branded beds and leaving that market altogether, and the US Food and Drug Administration has published an Early Alert telling patients, families and care facilities what to do next.
For anyone with an adjustable bed at home, in a nursing home or in a long-term care facility, the message is urgent but practical. Beds already in use do not have to be abandoned overnight, but they must now be used under stricter instructions until they are repaired or replaced. The most important change is simple: keep the bed unplugged except while you are actively repositioning the patient.
On October 29, 2026, the FDA's Center for Devices and Radiological Health published an Early Alert headed "Medline Removes or Corrects All Medline Brand Beds and Accessories." The alert says the FDA is aware that Medline has issued an Urgent Medical Device Field Safety Notice telling customers about the discontinuation and market exit of all Medline-brand beds and their associated pendants, accessories, replacement parts and bed-containing order packages. Medline recommends that these products be removed from where they are used or sold, or in some cases corrected before continued use.
Reuters reported the same day that the FDA had warned of safety risks associated with Medline beds and accessories after the company reported the two deaths and 16 serious injuries. A Medline spokesperson told Reuters the company was working with affected customers and healthcare providers to minimise disruption while prioritising patient safety.
The timeline matters, because this was not a single-day decision. Medline first notified customers on October 14, 2026, that it was removing the products from the market. On October 24, 2026, it issued an updated notice that changed the advice for beds already in use: instead of immediate removal in every case, those beds may remain in use under the new instructions until they are repaired or replaced. The FDA's October 29 Early Alert reflects that updated position and says the agency is still reviewing information about what it calls a potentially high-risk device issue, and will update its page as significant new information becomes available.
An adjustable, AC-powered hospital bed is a familiar piece of medical equipment: a bed with a built-in electric motor and remote controls that let the patient, or a carer, adjust its height and surface contour, with side rails that can be latched on or off and moved around. In homecare, such beds let people with limited mobility sleep, sit up and be repositioned at home rather than in hospital. In long-term care, they are used every day, often for years, by residents who may be unable to move themselves quickly if something goes wrong.
That is why the scope of this action is so striking. The FDA lists every Medline-brand bed category as affected: homecare beds, bariatric beds designed for heavier patients, and long-term care beds, along with pendants, accessories, replacement parts and bed-containing order packages. This is not a single model or a single batch. It is the whole branded bed range, and it ends with Medline leaving the bed market.
The FDA's page also points to a related earlier item, an "Electronic Homecare Bed Correction" from February 13, 2026, in which Medline updated use instructions for homecare beds. That history suggests the bed range has been under safety scrutiny before this week's market exit, although the October alert does not itself describe that earlier correction in detail. What is new now is the combination: a fire hazard, an entrapment hazard, a market exit, and a reported toll of two deaths and 16 serious injuries as of October 20.
The Medline beds FDA warning describes two distinct hazards, and families need to understand both, because they call for different precautions.
The first is fire. Medline has identified a potential fire hazard involving its beds, hand-control pendants, control and motor boxes, and actuators or motors. Under certain conditions, the bed's electrical components may overheat. The FDA lists the conditions that can contribute: excessive system loading, jammed components or motors, damage to or fluid getting into the pendant, the use of extension cords, or the use of non-Medline or unapproved pendants or accessories. Overheating may progress to smoking, sparking, melting, burning or fire. The consequences the FDA lists are stark: electrical shock and burns, and if a fire occurs, serious injury or death, including burns, chronic respiratory conditions from smoke inhalation, post-traumatic stress related to fire incidents, or fatality.
The second hazard is entrapment and asphyxiation. Through post-market surveillance, Medline received information about risk when any bed accessories are used. The FDA says there is a potential risk of entrapment or asphyxiation in three situations: if Medline-brand beds are used with any bed accessories, if a user lies on a pendant being used with the bed, or if the bed is used with loose or wobbly rails. Entrapment or asphyxiation may result in patient injury or death. For a patient who cannot reposition themselves, a rail gap, a trapped pendant or an accessory that creates a pinch point can become life-threatening before anyone notices.
It is important to be precise about what the published reports do and do not say. Neither the FDA alert nor the Reuters report breaks down how many of the two deaths and 16 serious injuries were caused by fire and how many by entrapment, and neither names individual patients. The figures are Medline's reports as of October 20, 2026, covering the issues together. Readers should therefore treat the toll as the combined reported toll for both hazards, not as a count for either hazard alone.
The FDA's own language is deliberately formal: it calls this an Early Alert to notify the public of a potentially high-risk device issue, and says it will keep the public informed and update the page as significant new information becomes available. That wording signals that the agency's review is ongoing, and that further detail, or a formal recall classification, could follow.
Medline's position, as reported by Reuters, is that it is working with affected customers and healthcare providers to minimise disruption while prioritising patient safety. The company's customer-facing instructions carry the practical weight: beds may remain in use only under the updated rules, and customers should contact Medline about repair, replacement or refund rather than attempting a fix themselves. The FDA repeats that warning in its own words: do not attempt to repair, modify or alter Medline-brand beds unless specifically instructed by Medline through a Medline-authorised repair process.
For care providers, the reaction that matters most will be operational. Nursing homes and homecare agencies must now check every bed, rail, mattress and accessory against the Medline brand, apply the unplug rule, remove extension cords, and arrange second-person help for repositioning where possible. For families caring for a relative at home, the same checks apply, and the Medline helpline is the route to a repair, a replacement or money back.
This warning matters for three reasons. First, the population affected is among the most vulnerable: people who depend on an adjustable bed because they cannot easily get up, move away from smoke, or free themselves if trapped. A hazard that would be an inconvenience for a healthy adult can be fatal for someone with limited mobility, and the reported deaths underline that point.
Second, the market exit changes the long-term picture. When a manufacturer leaves a product market, replacement parts, compatible accessories and servicing can become harder to find. Medline says it is establishing two paths for affected beds: repair for certain beds, and replacement or a full or partial refund of the original purchase price where repair is not possible. It adds that repair, replacement or refund may be available for certain beds, rails, mattresses and accessories purchased in the last five years, while products bought more than five years ago remain subject to the field action and the updated instructions. Families should therefore not assume an old bed is outside the action, and should not assume a new one is automatically covered for a refund: both questions go to Medline's customer service.
Third, the warning is a reminder of how everyday medical devices are regulated after sale. The hazards here were identified through post-market surveillance, the system by which problems reported by users and clinicians are collected after a device is on the market. The FDA's Early Alert mechanism exists precisely for this stage: to warn the public quickly, before a full review is complete, when the risk is potentially high. That speed is valuable, but it also means details may change, which is why the FDA tells readers to check its page for updates.
In the short term, Medline customers should take four steps. First, identify whether any bed, rail, mattress, pendant or accessory in use is a Medline-brand product, including bariatric and long-term care models. Second, apply the updated instructions immediately: unplug the bed from the outlet, plug it in only while repositioning the patient, unplug it again afterwards, do not use extension cords, and have a second person assist where possible. Third, contact Medline Recall Customer Service at 1-800-950-0128, option 7, to start the repair, replacement or refund process, and keep a note of the reference given. Fourth, report any adverse event to Medline at QualityAssurance@medline.com or 1-800-950-0128, option 5, and to the FDA's MedWatch programme.
If a bed shows smoke, sparks, melting, a burning smell or a pendant that feels hot, the bed should be unplugged and Medline contacted for service; if there is a fire or anyone is hurt, local emergency services should be called first. No one should try to repair or modify a bed on their own, and unapproved pendants or accessories should not be substituted.
Longer term, watch for three developments: the FDA's updated Early Alert page, any formal recall classification that follows the agency's ongoing review, and Medline's own recall page for its branded beds and accessories. Care facilities should also review their wider bed stock, because the entrapment lessons here, loose or wobbly rails, accessories that create gaps, and pendants left where a patient can lie on them, apply to adjustable beds generally, not only to one brand.
All Medline-brand beds and associated components: homecare beds, bariatric beds, long-term care beds, pendants, accessories, replacement parts and bed-containing order packages.
As of October 20, 2026, Medline had reported two deaths and 16 serious injuries associated with the fire, entrapment and asphyxiation issues combined. The published reports do not break the toll down by hazard.
Under Medline's updated October 24 instructions, yes, until the bed is repaired or replaced, but only if you follow the new rules: keep it unplugged except while repositioning, never use extension cords, and have a second person help where possible.
Contact Medline Recall Customer Service at 1-800-950-0128, option 7. Certain beds may be repaired; others may qualify for replacement or a full or partial refund. Products bought more than five years ago are still covered by the safety instructions.
The FDA has published this as an Early Alert and says it is still reviewing information about a potentially high-risk device issue. Check the FDA's page for updates, as further information or a formal classification may follow.
Related coverage on US News Pulse: the Bodum French press recall of 5.9 million coffee makers over burn risk, the Trader Joe's E. coli outbreak that ended after sickening 50 people, and the Virginia oysters Salmonella outbreak that sickened 27 people in 12 states.
Sources: FDA Early Alert, "Medline Removes or Corrects All Medline Brand Beds and Accessories," October 29, 2026; Reuters, "US FDA issues warning on Medline beds after 2 deaths, 16 serious injuries," October 29, 2026. Image: original illustration for US News Pulse; the bed shown is representative and is not a photograph of a specific Medline model.
Leave a Comment
| Today's Date:
